Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap389.98M
Enterprise Value369.74M
Trailing P/E15.99
Forward P/E24.98
PBYI
(NASDAQ)Puma Biotechnology, Inc.
$7.67-- (--)
Loading... - Market loading
Puma Biotechnology (PBYI) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)1.72
Forward Price/Sales1.76
Price/Book (mrq)3.04
Price/Tangible Book (mrq)4.36
Price/FCF (ttm)7.28
Price/OCF (ttm)7.27
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue1.63
EV/Earnings15.16
EV/EBITDA8.23
EV/EBIT9.61
EV/FCF6.90
Stock Price
Current price, 52-week range, and moving averages
Current Price$7.67
1-Day Change-3.52%
52-Week High$8.41
52-Week Low$3.03
52-Week Change131.72%
YTD Change32.93%
1-Year Change131.72%
50-Day MA$7.28
200-Day MA$6.19
Avg Volume (30 day)234.17K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding50.85M
Book Value per Share$2.53
Net Cash per Share$0.40
FCF per Share$1.05
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin74.46%
EBITDA Margin (ttm)19.77%
EBIT Margin (ttm)16.93%
Operating Margin (ttm)12.98%
Pretax Margin (ttm)12.80%
Profit Margin (ttm)10.73%
FCF Margin (ttm)23.59%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)18.99%
Return on Assets (ttm)12.65%
Return on Invested Capital (ttm)29.80%
Return on Capital Employed (ttm)28.92%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue227.18M
Gross Profit169.15M
Operating Income29.49M
Pretax Income29.09M
Net Income24.38M
EBITDA44.91M
EBIT38.46M
Diluted EPS$0.48
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow53.61M
Capital Expenditures10.00K
Free Cash Flow53.60M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth-2.38%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)192.70M
Cash & Securities (mrq)36.20M
Net Cash (mrq)20.25M
Net Cash per Share$0.40
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)15.95M
Working Capital (mrq)82.52M
Total Equity (mrq)128.42M
Book Value per Share$2.53
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)2.38
Quick Ratio (mrq)2.24
Debt/Equity (mrq)0.12
Debt/EBITDA (ttm)0.36
Debt/FCF (ttm)0.30
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield6.25%
FCF Yield13.74%
Buyback Yield-0.03%
Total Shareholder Yield-0.03%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-15.53
Piotroski F-Score7/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$1.69
Lynch Upside/Downside-77.95%
Graham Number$5.22
Graham Upside/Downside-31.95%
Frequently Asked Questions About Puma Biotechnology Statistics
What are the key financial metrics for PBYI?
Puma Biotechnology, Inc. (PBYI) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is PBYI's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Puma Biotechnology is overvalued or undervalued.
How do I read PBYI's profitability ratios?
Puma Biotechnology's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do PBYI's debt ratios indicate?
The financial health section shows Puma Biotechnology's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is PBYI's dividend analysis?
The dividend section covers Puma Biotechnology's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.